LFR a bacterium (MRSA, yellow) being ingested by an immune cell (Neutrophil, purple)LFR lung cancer cell during cell divisionMoores Cancer Center

NCI logoOne revolutionary building brings together research, education, and clinical care where our clinicians and scientists advance patient care through translational research. As an NCI-designated comprehensive cancer center, Moores Cancer Center is at the forefront of the fight against cancer. From research in molecular genetics to the most advanced clinical treatments, we are developing promising new therapies and making them available to cancer patients throughout the region. Read More >

UC San Diego Researchers Convert Pro-Tumor Macrophages into Cancer Killers

Epithelial cancers, such as cancers of the lung and pancreas, use the ανβ3 molecule to gain drug resistance to standard cancer therapies and to become highly metastatic. In a paper published in Cancer Research, University of California San Diego School of Medicine researchers, led by Professor David Cheresh, identified a new therapeutic approach in mouse models that halts drug resistance and progression by using a monoclonal antibody that induces the immune system to seek and kill ανβ3-expressing cancer cells. Read more in press release.

Upcoming Events

4th Annual Biorepository and Tissue Technology Shared Resource Symposium 

Date: December 9, 2019
Time: 8:30 AM to 1:00 PM (PDT)
Location: The Commons, 2nd Floor, Moores Cancer Center
Keynote Speaker: Sarah Dry, MD (UCLA) 
Register here
Learn more